The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
about
CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axisRole of stromal cell-derived factor 1α pathway in bone metastatic prostate cancerIncreased Oxidative Stress as a Selective Anticancer TherapyHigh Throughput Label Free Measurement of Cancer Cell Adhesion Kinetics Under Hemodynamic Flow.Cis-regulatory functions of overlapping HIF-1alpha/E-box/AP-1-like sequences of CD164.Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membrane.Role of IGF2BP3 in trophoblast cell invasion and migrationABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.A high-throughput mechanofluidic screening platform for investigating tumor cell adhesion during metastasis.Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.The evolving biology and treatment of prostate cancer.The role of novel and known extracellular matrix and adhesion molecules in the homeostatic and regenerative bone marrow microenvironmentApical targeting and endocytosis of the sialomucin endolyn are essential for establishment of zebrafish pronephric kidney functionHematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors.Structure and function of the solid tumor niche.The prostate cancer bone marrow niche: more than just 'fertile soil'.The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites.Adhesion molecules in endometrial epithelium: tissue integrity and embryo implantation.A multi-targeted approach to treating bone metastases.CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma.Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo.Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer.CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214.CD164 promotes lung tumor-initiating cells with stem cell activity and determines tumor growth and drug resistance via Akt/mTOR signaling.CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sézary syndrome patients.Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes.What makes cancer stem cell markers different?The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios.Overexpression of CD164 in oral cavity squamous cell carcinoma predicts a favourable prognosis.Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma.Loss and gain of N-linked glycosylation sequons due to single-nucleotide variation in cancer.
P2860
Q24337710-EADA2161-E807-4F2A-851E-368D9027616FQ26741064-62E07776-15FC-4A2F-AACC-AE2C77243CBBQ26798210-3EE8209C-803F-4264-9E20-92A8ECB29201Q30392061-976760E5-1211-4273-8327-37385C51C572Q31039180-27811418-2A52-43B7-8D14-D8EAD15B9DA2Q33576873-EE75EBFB-221B-4CD6-AE6E-F600E4AB2713Q33694962-3B7144CF-4A28-49D6-9681-2A9E7C31793EQ34252280-D6980B61-642C-4298-A0BE-C8519CCC964EQ35846178-BB4DAC2C-A5A0-4331-BC56-3321A1639B5EQ35916537-FA6EFD8E-B553-458D-89F7-D8317AEE6BCBQ35951473-C9539F18-4D88-404B-B49A-1F60343D89CDQ36124907-E245FF24-A0CC-43CB-9F3B-D34F73294FEEQ36580550-CA6AB7B2-C10E-4F35-8156-237D4219284DQ36670789-BBACC201-3932-4CF7-B423-B2E85B087431Q36676448-8B8E7820-AA84-4E93-8667-BDD27626953DQ36700788-E88C556C-7C19-4201-BC36-28A15FB8B4B2Q37096553-A9B25E3A-A75F-4071-BED2-DCAFC0C24374Q37488290-350D8638-55FA-4FB2-93EF-83C300FEB552Q38175846-79EA84BE-9DE5-4524-8FE7-7E0B84BD895CQ38713844-86BA54E8-8B61-43BD-94FB-9D91570CEB48Q39381393-094B12B8-AC79-4625-BC06-A86051E46A99Q39534721-55FC0B5E-B3B9-4ED0-9667-68751F34070AQ40527083-F05FAB2C-C65E-427D-84EA-DCA1D89CED36Q41553115-A0E50BA0-3964-49D6-A939-FAAF1B3F702FQ42084033-8F230992-19A9-4BBB-8BC1-CADFC24139E5Q42509521-F18B5277-065D-4C05-AA6D-DB2237CBF86DQ43093172-1DD8C8F2-9395-4CB9-A66D-C6D1879AEC13Q46207048-20EE6365-7C77-4D89-AD00-F264BAD39596Q47131012-00C6A26A-F5D1-4D34-9205-9FCE24F54DD1Q49732125-98F3498C-371D-461A-8680-A8C1008743A2Q55053200-F12D97E6-282F-460A-8A65-E49FA5C84C89
P2860
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@ast
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@en
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@en-gb
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@nl
type
label
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@ast
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@en
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@en-gb
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@nl
prefLabel
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@ast
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@en
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@en-gb
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@nl
P2093
P2860
P356
P1433
P1476
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
@en
P2093
P2860
P2888
P356
10.1186/1471-2407-6-195
P407
P577
2006-07-21T00:00:00Z
P5875
P6179
1036601817